About Index Trending news
Analyze
Top 50 Pricing
BIND Therapeutics

BIND Therapeutics

Work at BIND Therapeutics? Add yourself to this profile

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series D)
$25,500,000
Venture capital (Series C)
$12,400,000
Employees

Team size

50+
Locations
HQ
Xconomy

Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

Xconomy

Bind Therapeutics Sheds Employees, Considers New Capital or Deals

Health Funding